SEC Form 4 · accession 0001053369-15-000014
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ashok G Nigalaye
Director · 10% Owner
Period of report
Apr 16, 2015
Accepted (ET)
Apr 16, 2015 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Apr 16, 2015 | G | 1,250,000 | D | Jun 3, 2009 | Jun 3, 2016 | Common Stock | 1,250,000 | 1,204,665 | D |